Magnetar Financial LLC Karuna Therapeutics, Inc. Transaction History

Magnetar Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$161.01 - $317.85 $31.9 Million - $63 Million	198,264 Added 5082.39%	202,165 $64 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $191,170 - $253,190	1,161 Added 42.37%	3,901 $659,000
Q2 2023 Aug 11, 2023	SELL	$176.32 - $240.22 $195,538 - $266,403	-1,109 Reduced 28.81%	2,740 $594,000
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $115,996 - $146,934	-719 Reduced 15.74%	3,849 $699,000
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $341,306 - $422,013	-1,782 Reduced 28.06%	4,568 $898,000

Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $398,232 - $892,460	3,217 Added 102.68%	6,350 $1.43 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $294,408 - $449,052	3,133 New	3,133 $396,000

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.